Literature DB >> 31175017

Radiation Management in Coronary Angiography: Percutaneous Coronary Intervention for Chronic Total Occlusion at the Frontier.

Glenn R Ison1, Usaid Allahwala2, James C Weaver3.   

Abstract

The usage of ionising radiation in medical investigations and procedures continues to increase. Cardiologists are responsible for a disproportionately high amount of this radiation, and the performance of percutaneous coronary intervention for chronic total occlusions (CTO PCI) often requires particularly high radiation doses. Consequently, both patients and proceduralists are potentially being exposed to harmful doses of radiation. This review discusses the potential dangers of radiation exposure during CTO PCI, as well as techniques to minimise radiation dose to the patient and proceduralist. Specific attention is paid to recent innovations in real-time dose monitoring and X-ray system developments that afford considerable dose savings during routine PCI as well as CTO PCI. Crown
Copyright © 2019. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic total occlusion; Noise reduction technology; Radiation dose; Radiation minimisation

Mesh:

Year:  2019        PMID: 31175017     DOI: 10.1016/j.hlc.2019.05.004

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  2 in total

Review 1.  The indications and utility of adjunctive imaging modalities for chronic total occlusion (CTO) intervention.

Authors:  Usaid K Allahwala; Emmanouil S Brilakis; Hosen Kiat; Sally Ayesa; Daniel Nour; Michael Ward; Sidney Lo; James C Weaver; Ravinay Bhindi
Journal:  J Nucl Cardiol       Date:  2020-10-06       Impact factor: 5.952

2.  Occupational and Patient Radiation Dose and Quality Implications of Femoral Access Imaging During Coronary Angiography.

Authors:  Kelly Wilson-Stewart; Davide Fontanarosa; Eva Malacova; Steven Gett; Allan Kruger; Jamie V Trapp
Journal:  J Multidiscip Healthc       Date:  2021-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.